InsidersTradesSigma
Follow the 유유제약 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 유유제약 has logged 68 reports. Market capitalisation: €56.1bn. The latest transaction was filed on 1 July 2026 (Other). Among the most active insiders: 유원상. The full history is free.
67
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,239 of 29,057 companies
72.7
score / 100
Value90
Quality56
FCF yld12%
Earn yld13%
EV/EBITDA5.1x
ROE8.8%
Gross mgn38%
Net mgn5.8%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 July 2026
Declarations68 total
Other
25 of 68 declarations
关于 유유제약
유유제약 是一家韩国制药公司，专注于药物的开发和营销。该公司在韩国证券交易所上市。